CRIS
CURIS INC
Key Financials
Net Income
$-7582000
↑ 82.5%
Revenue
$9.4M
↓ 13.4%
EPS (Diluted)
$-0.58
↑ 91.6%
Total Liabilities
$14.5M
↓ 69.3%
Operating Income
$-5713000
↑ 87.2%
Cash & Equivalents
$5.1M
↓ 74.7%
Long-term Debt
$900000.00
0.0%
Total Assets
$20.0M
↓ 51.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/14/2026 | View on SEC |
| 424B4 | 8/13/2026 | View on SEC |
| EFFECT | 8/12/2026 | View on SEC |
| S-1 | 8/10/2026 | View on SEC |
| 8-K | 7/30/2026 | View on SEC |
| DRS | 7/17/2026 | View on SEC |
| 4 | 7/9/2026 | View on SEC |
| 4 | 7/9/2026 | View on SEC |
| 4 | 7/9/2026 | View on SEC |
| 4 | 7/9/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CRIS |
| Company Name | CURIS INC |
| CIK | 1108205 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-503-6500 |